Previously, a distinct function of FOXO1 in HDI-mediated autophagy in human cancer cells was reported, suggesting the possibility of a novel therapeutic strategy by combining HDIs and autophagy inhibitors in cancer therapy 19. This evidence concerns the gene FOXO1 and cancer.